{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:15:10Z","timestamp":1792739710976,"version":"4.5.0"},"reference-count":75,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2004,5,12]],"date-time":"2004-05-12T00:00:00Z","timestamp":1084320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Aims\u2003<\/jats:bold> To ascertain the efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence.<\/jats:p><jats:p><jats:bold>Methods\u2003<\/jats:bold> Systematic review of the literature (1990\u20132002) and meta\u2010analysis of full published randomized and controlled clinical trials assessing acamprosate or naltrexone therapy in alcohol dependence. Estimates of effect were calculated according to the fixed\u2010effects model.<\/jats:p><jats:p><jats:bold>Measurements\u2003<\/jats:bold> Relapse and abstinence rates, cumulative abstinence duration and treatment compliance were considered as primary outcomes.<\/jats:p><jats:p><jats:bold>Findings\u2003<\/jats:bold> Thirty\u2010three studies met the inclusion criteria. Acamprosate was associated with a significant improvement in abstinence rate [odds ratio (OR): 1.88 (1.57, 2.25),\u2003<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001] and days of cumulative abstinence [WMD: 26.55 (17.56, 36.54]. Short\u2010term administration of naltrexone reduced the relapse rate significantly [OR: 0.62 (0.52, 0.75),\u2003<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001], but was not associated with a significant modification in the abstinence rate [OR: 1.26 (0.97,1.64), <jats:italic>P<\/jats:italic>\u2003=\u20030.08]. There were insufficient data to ascertain naltrexone's efficacy over more prolonged periods. Acamprosate had a good safety pattern and was associated with a significant improvement in treatment compliance [OR: 1.29 (1.13,1.47),\u2003<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001]. Naltrexone's side effects were more numerous, yet the drug was nevertheless tolerated acceptably without being associated with a lower adherence to treatment (OR: 0.94 (0.80, 1.1), <jats:italic>P<\/jats:italic>\u2003= 0.5). However, overall compliance was relatively low with both medications.<\/jats:p><jats:p><jats:bold>Conclusions\u2003<\/jats:bold> Both acamprosate and naltrexone are effective as adjuvant therapies for alcohol dependence in adults. Acamprosate appears to be especially useful in a therapeutic approach targeted at achieving abstinence, whereas naltrexone seems more indicated in programmes geared to controlled consumption. Both drugs are safe and acceptably tolerated but issues of compliance need to be addressed adequately to assure their usefulness in clinical practice.<\/jats:p>","DOI":"10.1111\/j.1360-0443.2004.00763.x","type":"journal-article","created":{"date-parts":[[2004,6,11]],"date-time":"2004-06-11T10:32:46Z","timestamp":1086949966000},"page":"811-828","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":366,"title":["Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review"],"prefix":"10.1111","volume":"99","author":[{"given":"Bouza","family":"Carmen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magro","family":"Angeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu\u00f1oz","family":"Ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amate Jos\u00e9","family":"Mar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,5,12]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1996.tb01658.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505113321901"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7104.358"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905133401907"},{"key":"e_1_2_7_6_2","volume-title":"Treatment Improvement Protocol (TIP) Series 28.","author":"O'Malley S. S.","year":"1998"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2001.tb02386.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853899009147920"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.9579993.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820110045007"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820110040006"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/36.1.2"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1993.tb05664.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1995.90911793.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(96)00019-4"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(99)00204-8"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(97)00134-8"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.64.5.1044"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v19n01_06"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1998.tb04295.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/35.2.176"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000259166"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/36.5.413"},{"key":"e_1_2_7_25_2","first-page":"182","article-title":"Acamprosate\u2014a stabilizing factor in long\u2010term withdrawal of alcoholic patients","volume":"50","author":"Ladewig D.","year":"1993","journal-title":"Therapeutische Umschau"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.alcalc.a045057"},{"key":"e_1_2_7_27_2","first-page":"239","article-title":"Double\u2010blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol","volume":"30","author":"Paille F. M.","year":"1995","journal-title":"Alcohol and Alcoholism"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.171.1.73"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb02873.x"},{"key":"e_1_2_7_30_2","first-page":"65","article-title":"Does acamprosate diminish the appetite for alcohol in weaned alcoholics?","volume":"51","author":"Roussaux J. P.","year":"1996","journal-title":"Journal de Pharmacie de Belgique"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830080023006"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/35.2.202"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91682-7"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.11.1758"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200102000-00013"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/35.6.587"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830240090013"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2002.tb02682.x"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200106000-00006"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050688"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1999.10471767"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(99)00135-9"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011127"},{"key":"e_1_2_7_44_2","first-page":"97","article-title":"Naltrexone in the treatment of alcoholism: two\u2010year follow up results","volume":"13","author":"Landabaso M. A.","year":"1999","journal-title":"European Journal of Psychiatry"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2002.tb04550.x"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2001.tb02170.x"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.961115654.x"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830030039007"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-199700540-00007"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/36.5.419"},{"key":"e_1_2_7_51_2","first-page":"39","article-title":"Naltrexone in the treatment of alcoholism: predicting response to naltrexone","volume":"56","author":"Volpicelli J. R.","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830200071010"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199753060-00008"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199917030-00005"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2001.tb02356.x"},{"key":"e_1_2_7_56_2","unstructured":"Berglund M. Andreasson S.&Franck J.(2002)Treatment of alcohol and drug abuse\u2014an evidence\u2010based review.http:\/\/www.sbu.se\/admin\/Docs\/PUB\/833\/drugslut.htm. Accessed 21 January 2003."},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.3109\/10826089509055828"},{"key":"e_1_2_7_58_2","article-title":"Opioid antagonists for alcohol dependence (Cochrane Review)","volume":"1","author":"Srisurapanont M.","year":"2002","journal-title":"Cochrane Library"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/36.6.544"},{"key":"e_1_2_7_60_2","article-title":"Pharmacotherapy for alcohol dependence. Summary, evidence report\/technology assessment","volume":"3","author":"West S. L.","year":"1999","journal-title":"Agency for Health Care Policy and Research"},{"key":"e_1_2_7_61_2","doi-asserted-by":"publisher","DOI":"10.3109\/10826089409047908"},{"key":"e_1_2_7_62_2","volume-title":"The Handbook of Research Synthesis","author":"Fleiss J.","year":"1994"},{"key":"e_1_2_7_63_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7314.681"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/37.4.375"},{"key":"e_1_2_7_65_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000666"},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/hec.609"},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2001.tb02325.x"},{"key":"e_1_2_7_68_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7124.61"},{"key":"e_1_2_7_69_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500210049030"},{"key":"e_1_2_7_70_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta4100"},{"key":"e_1_2_7_71_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta7010"},{"key":"e_1_2_7_72_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7126.221"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462300103150"},{"key":"e_1_2_7_74_2","first-page":"812","article-title":"Guides for reading and interpreting systematic reviews. II. How did the authors find the studies and assess their quality","volume":"152","author":"Jadad A. R.","year":"1999","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"key":"e_1_2_7_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(91)90160-B"},{"key":"e_1_2_7_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117248"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1360-0443.2004.00763.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1360-0443.2004.00763.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:09:05Z","timestamp":1697504945000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1360-0443.2004.00763.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,12]]},"references-count":75,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1111\/j.1360-0443.2004.00763.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1360-0443.2004.00763.x","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,12]]},"assertion":[{"value":"2004-05-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}